Microarrays Inc. New Products: Microarrays Inc.'s Custom Laboratory Services Premium Microarrays Inc. is now offering custom laboratory services for gene expression projects. New Product Watch: Oct 25, 2011 Premium Microarrays Inc. this week launched three MI PathArray assays for studying targeted biological pathways. The new arrays cover pathways associated with apoptosis, growth factors, and inflammation. Microarrays Inc. to Debut Focused Arrays for Growth Factor, Inflammation, and Apoptosis Studies Premium By Justin Petrone VCs, Researchers, Vendors Agree: When It Comes to Funding, Arrays Face Difficult Times Premium By Justin Petrone Microarrays Inc. Expands into European Market with Three Distribution Deals Premium The Huntsville, Ala.-based firm has tapped Cambio to distribute its products in the UK and Ireland; BioCat to cover Germany, Austria, and Switzerland; and Biosolutions to sell its arrays to customers in Cyprus, Greece, and other Balkan countries. Feb 8, 2011 People in the News: Feb 8, 2011 Premium Jul 19, 2010 Vanderbilt University Sells Microarrays to Management Team Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.